01
Jun
European consortium to create bio-electronic implants to treat Multiple Sclerosis
in General
Comments
Barcelona, 1st June, 2017 – Researchers from eleven institutions and companies in seven different European countries have started work within the Optogenerapy consortium to develop optogenetic cellular therapy implants by means of printed electronics with biocompatible materials that will enable the administration of therapeutic protein doses for patients with multiple sclerosis, an illness that affects 2.3 million people all over the world and 700,000 in...
Read More